Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New U.K. NHS Bodies Authorize Avastin Use In AMD As Lucentis Pricing Pressures Continue

14 Nov 2011

• By John Davis

Related Content

Lucentis And Avastin Stack Up In CATT, Forcing Genentech/Novartis To Play Defense

28 Apr 2011

Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies

31 Aug 2011

Roche's Avastin Pay-For Performance Deal: The Future Of German Health Care?

28 Oct 2011

Changes To The NHS: How Can Pharma Best Position Itself?

31 Jan 2011

With Its Economy Struggling, Spain Launches Second Cost-Cutting Exercise In Two Years

08 Aug 2011

Preparing For A Pricing Shift: Roche Admits Cost Is An Issue In Oncology And Beyond

27 Jun 2011

Related Companies

Roche Holding AG

Novartis AG

Additional Topics

Europe BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.